Haleon’s pilot run of the screener analysed 1,500 pieces of creative for the Panadol pain relief brand across nine markets.

由$葛兰素史克(GSK)$、$辉瑞(PFE)$、和盐野意（Shionogi）共同拥有的ViiV Healthcare发布药物Apretude作为预防艾滋病毒感染的暴露前预防（PrEP）治疗的有效性超过99%。 该公司表示，这些数据强调了长效卡波特韦制剂Apretude的高依从率和有效性。根据一份声明，这些数据将在10月16日至19日在洛杉矶举行的IDWeek 2024会议上公布。$吉利德科学(GI ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

Gaziemir GSK vs Şirinyerspor team performances, predictions and head to head team stats for goals, first half goals, corners, ...

GSK Ireland released new data from an Irish survey this week, commissioned and funded by GSK, highlighting some significant ...

The statement read: “NAFDAC enforcement officers, aided by intelligence from the Nigerian Army’s 15 Field Engineering ...

GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine ...

GSK (NYSE:GSK) continued losses for a seventh straight session as the stock closed 0.61% lower, at $37.51 on Friday.  The ...

Governor Josh Shapiro and GSK leadership announced the global biopharma company’s major investment of up to $800 million in ...

The growth of the DEE treatment market can be attributed to the increasing prevalence of developmental and epileptic ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.